[Over-the-border evidence: the relevance of results of non-Western RCTs].
Increasing numbers of randomised-controlled trials are performed in non-Western countries. The main reason for this tendency are the lower costs needed to perform trials in non-Western countries. It has been shown that results from trials performed in non-Western countries sometimes overestimate the effects compared to trials with the same intervention performed in Western countries. This means that results from trials performed in non-Western countries are not automatically generalisable to Western countries.